Buffer-Free High Performance Liquid Chromatography Method for the Determination of Theophylline in Pharmaceutical Dosage Forms
Purpose: To develop and validate a simple, economical and reproducible high performance liquid chromatographic (HPLC) method for the determination of theophylline in pharmaceutical dosage forms.
Method: Caffeine was used as the internal standard and reversed phase C-18 column was used to elute the drug and standard. The mobile phase was prepared by mixing water:acetonitrile:methanol at the ratio of 90:03:07 and the pH set at 4.6. Flow rate and ultraviolet (UV) detector were set at 1.0 mLmin-1 and 271 nm, respectively. The method was validated for linearity, recovery, accuracy, precision, specificity, and also for inter-day stability under laboratory conditions.
Results: Retention time was 5.5 min. The limits of detection and quantification were 12.5 ngmL-1 and 100 ngmL-1, respectively. Recovery accuracy (%) for different concentrations ranged from 100.05 to 102.43; regression coefficient (R2) of 0.994; precision RSD < 2.0, and negligible interference from common excipients.
Conclusion: The method is simple, rapid, highly specific and suitable for the determination of theophylline. Absence of buffer and use of small quantity of organic solvents increase the life span of the column and reduce the cost of routine analysis of theophylline in industry.
Keywords : Buffer-free, High performance liquid chromatography, Theophylline, Dosage form.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.